405 related articles for article (PubMed ID: 21057539)
61. Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation.
Iizuka D; Imaoka T; Nishimura M; Kawai H; Suzuki F; Shimada Y
Radiat Res; 2013 Feb; 179(2):151-9. PubMed ID: 23273170
[TBL] [Abstract][Full Text] [Related]
62. The role of miR-100 in regulating apoptosis of breast cancer cells.
Gong Y; He T; Yang L; Yang G; Chen Y; Zhang X
Sci Rep; 2015 Jul; 5():11650. PubMed ID: 26130569
[TBL] [Abstract][Full Text] [Related]
63. α4 is highly expressed in carcinogen-transformed human cells and primary human cancers.
Chen LP; Lai YD; Li DC; Zhu XN; Yang P; Li WX; Zhu W; Zhao J; Li XD; Xiao YM; Zhang Y; Xing XM; Wang Q; Zhang B; Lin YC; Zeng JL; Zhang SX; Liu CX; Li ZF; Zeng XW; Lin ZN; Zhuang ZX; Chen W
Oncogene; 2011 Jun; 30(26):2943-53. PubMed ID: 21339737
[TBL] [Abstract][Full Text] [Related]
64. Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.
Goldberger N; Walker RC; Kim CH; Winter S; Hunter KW
Cancer Res; 2013 Apr; 73(8):2671-81. PubMed ID: 23447578
[TBL] [Abstract][Full Text] [Related]
65. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.
Zhang X; Wu M; Chong QY; Zhang W; Qian P; Yan H; Qian W; Zhang M; Lobie PE; Zhu T
Carcinogenesis; 2018 Dec; 39(12):1506-1516. PubMed ID: 30084985
[TBL] [Abstract][Full Text] [Related]
66. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
67. The oncogenic role of miR-155 in breast cancer.
Mattiske S; Suetani RJ; Neilsen PM; Callen DF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1236-43. PubMed ID: 22736789
[TBL] [Abstract][Full Text] [Related]
68. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
Lim WK; Micklem G
Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y
Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570
[TBL] [Abstract][Full Text] [Related]
71. Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells.
Qian P; Banerjee A; Wu ZS; Zhang X; Wang H; Pandey V; Zhang WJ; Lv XF; Tan S; Lobie PE; Zhu T
Cancer Res; 2012 Nov; 72(22):6036-50. PubMed ID: 23019226
[TBL] [Abstract][Full Text] [Related]
72. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
73. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
[TBL] [Abstract][Full Text] [Related]
74. Let-7a regulation of insulin-like growth factors in breast cancer.
Lu L; Katsaros D; Zhu Y; Hoffman A; Luca S; Marion CE; Mu L; Risch H; Yu H
Breast Cancer Res Treat; 2011 Apr; 126(3):687-94. PubMed ID: 20848182
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
76. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression.
Pagliuca A; Valvo C; Fabrizi E; di Martino S; Biffoni M; Runci D; Forte S; De Maria R; Ricci-Vitiani L
Oncogene; 2013 Oct; 32(40):4806-13. PubMed ID: 23128394
[TBL] [Abstract][Full Text] [Related]
77. Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells.
Brognara E; Fabbri E; Aimi F; Manicardi A; Bianchi N; Finotti A; Breveglieri G; Borgatti M; Corradini R; Marchelli R; Gambari R
Int J Oncol; 2012 Dec; 41(6):2119-27. PubMed ID: 22992757
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
Zhu S; Wu H; Wu F; Nie D; Sheng S; Mo YY
Cell Res; 2008 Mar; 18(3):350-9. PubMed ID: 18270520
[TBL] [Abstract][Full Text] [Related]
79. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
[TBL] [Abstract][Full Text] [Related]
80. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Han HB; Gu J; Zuo HJ; Chen ZG; Zhao W; Li M; Ji DB; Lu YY; Zhang ZQ
J Pathol; 2012 Feb; 226(3):544-55. PubMed ID: 21984339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
